Literature DB >> 13182239

Tetanus treated with tubocurarine and intermittent positive-pressure respiration.

G E HONEY, B E DWYER, A C SMITH, J M SPALDING.   

Abstract

Entities:  

Keywords:  CURARE/derivatives; RESPIRATION, ARTIFICIAL; TETANUS/therapy

Mesh：

Substances：

Year:  1954        PMID： 13182239      PMCID： PMC2078898          DOI： 10.1136/bmj.2.4885.442

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Metabolic disorders in head injury; survey of 76 consecutive cases.

Authors:  G HIGGINS; J R O'BRIEN; W LEWIN; W H TAYLOR
Journal:  Lancet       Date:  1954-01-09       Impact factor: 79.321

2.  Respiration pump for poliomyelitis.

Authors:  W R RUSSELL; E SCHUSTER
Journal:  Lancet       Date:  1953-10-03       Impact factor: 79.321

3.  Diagnostic and therapeutic clues in the study of tetanus.

Authors:  R P SCHMIDT; L L LEVY; R C TURRELL; W E HOPKINS; B M BLOOR; E ROSEMAN
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-01

4.  Succinylcholine in the treatment of tetanus.

Authors:  R WOOLMER; J E CATES
Journal:  Lancet       Date:  1952-10-25       Impact factor: 79.321

5.  A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency.

Authors:  H C A LASSEN
Journal:  Lancet       Date:  1953-01-03       Impact factor: 79.321

6.  [Curare, tracheotomy and nitrous oxide-oxygen overpressure ventilation in therapy a case of tetanus].

Authors:  A BJØRNEBOE; B IBSEN; S JOHNSEN
Journal:  Ugeskr Laeger       Date:  1953-10-15

7.  Two cases of tetanus treated with myanesin.

Authors:  L W PLEWES; D WILSON
Journal:  Anaesthesia       Date:  1951-01       Impact factor: 6.955
  7 in total
  2 in total

1.  The work of a respiratory unit in a neurological hospital.

Authors:  J MARSHALL
Journal:  Postgrad Med J       Date:  1961-01       Impact factor: 2.401

2.  Tubadil in ophthalmic surgery; its effect on intra-ocular pressure.

Authors:  R BRYCE-SMITH; F K BOSTON
Journal:  Br J Ophthalmol       Date:  1959-04       Impact factor: 4.638
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.